Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas A. Berthiaume currently holds 2,144,365 shares of GENZYME CORP (GENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas A. Berthiaume has been a net seller of GENZ stock. They have purchased $0 and sold $67.0M worth of shares.
Douglas A. Berthiaume's most recent insider trade was on Nov 3, 2017, when they sold 5,200 shares at $0.00 per share.
Douglas A. Berthiaume serves as Executive at GENZYME CORP (GENZ). They have executed 104 insider transactions totaling $67.0M over their tenure at the company.
Douglas A. Berthiaume holds the position of Executive at GENZYME CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Douglas A. Berthiaume has shown a selling trading pattern, with $0 in total purchases and $67.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Douglas A. Berthiaume was on Dec 4, 2014, when they sold $12.0M worth of WAT shares. This transaction involved 102,423 shares at $117.00 per share.
Douglas A. Berthiaume currently owns 2,144,365 shares of GENZYME CORP (GENZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas A. Berthiaume's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas A. Berthiaume has 104 Form 4 filings on record as an insider at GENZYME CORP.
Set alerts for Douglas A. Berthiaume and 40,000+ other insiders.